当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析 - 现金流量表

悦康药业

(688658)

  

流通市值:113.40亿  总市值:113.40亿
流通股本:4.50亿   总股本:4.50亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,385,776,592.31666,594,870.054,259,122,192.363,220,206,476.27
  收到的税费返还5,493,803.36-25,751,610.0221,973,726.35
  收到其他与经营活动有关的现金82,900,935.435,030,867.677,170,649.0284,732,787.47
  经营活动现金流入小计1,474,171,331.07701,625,737.654,362,044,451.43,326,912,990.09
  购买商品、接受劳务支付的现金433,501,407.03221,922,347.561,221,417,656.91942,665,986.88
  支付给职工以及为职工支付的现金225,969,206.86116,478,783.16455,922,125.22338,110,602.64
  支付的各项税费101,684,294.7641,483,283.07393,256,127.88276,388,368.4
  支付其他与经营活动有关的现金720,238,872.42240,699,690.671,853,207,888.91,339,262,185.77
  经营活动现金流出小计1,481,393,781.07620,584,104.463,923,803,798.912,896,427,143.69
  经营活动产生的现金流量净额-7,222,45081,041,633.19438,240,652.49430,485,846.4
二、投资活动产生的现金流量:
  收回投资收到的现金190,000,00060,000,000--
  取得投资收益收到的现金1,658,444.41865,853.74222,284.82-
  处置固定资产、无形资产和其他长期资产收回的现金净额848.5848.5626,753.041,315,297.18
  收到的其他与投资活动有关的现金72,191.785,072,191.78--
  投资活动现金流入小计191,731,484.6965,938,894.02849,037.861,315,297.18
  购建固定资产、无形资产和其他长期资产支付的现金84,903,020.9357,707,427.51358,601,267.73258,419,986.01
  投资支付的现金360,000,000-175,000,00063,006,500
  取得子公司及其他营业单位支付的现金--3,006,500-
  支付其他与投资活动有关的现金-10,000,00010,000,000-
  投资活动现金流出小计444,903,020.9367,707,427.51546,607,767.73321,426,486.01
  投资活动产生的现金流量净额-253,171,536.24-1,768,533.49-545,758,729.87-320,111,188.83
三、筹资活动产生的现金流量:
  取得借款收到的现金128,588,063.975,588,063.9649,010,636.01457,673,304.58
  收到其他与筹资活动有关的现金---66,000,000
  筹资活动现金流入小计128,588,063.975,588,063.9649,010,636.01523,673,304.58
  偿还债务支付的现金43,262,041.025,320,000510,440,317.6218,615,708
  分配股利、利润或偿付利息支付的现金9,786,823.954,706,325.39111,248,556.6103,843,133.07
  支付其他与筹资活动有关的现金71,535,122.541,831,185.9255,781,586.3204,469,831.08
  筹资活动现金流出小计124,583,987.5111,857,511.31677,470,460.5526,928,672.15
  筹资活动产生的现金流量净额4,004,076.3963,730,552.59-28,459,824.49-3,255,367.57
四、汇率变动对现金及现金等价物的影响107,617.2344,062.23263,852.38502,565.99
五、现金及现金等价物净增加额-256,282,292.62143,047,714.52-135,714,049.49107,621,855.99
  加:期初现金及现金等价物余额1,237,819,140.81,237,811,661.251,373,533,190.291,373,533,190.29
  期末现金及现金等价物余额981,536,848.181,380,859,375.771,237,819,140.81,481,155,046.28
补充资料:
  净利润-102,180,151.14-121,246,883.89-
  资产减值准备18,583,861.35-100,545,979.23-
  固定资产和投资性房地产折旧88,571,446.89-175,482,812.96-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧88,571,446.89-175,482,812.96-
  无形资产摊销13,579,767.71-23,957,891.98-
  长期待摊费用摊销2,315,152.5-4,169,393.21-
  处置固定资产、无形资产和其他长期资产的损失--383,536.49-
  固定资产报废损失49,686.11-1,918,171.53-
  公允价值变动损失---2,344,894.08-
  财务费用11,047,688.87-22,441,984.99-
  投资损失-1,385,511.85--477,284.82-
  递延所得税-1,855,297.92--9,928,933.09-
  其中:递延所得税资产减少-1,855,297.92--9,928,933.09-
  存货的减少159,885,223.75--59,153,628.01-
  经营性应收项目的减少134,209,866.78-276,645,562.46-
  经营性应付项目的增加-335,048,781.15--218,898,634.38-
  现金的期末余额981,536,848.18-1,237,819,140.8-
  减:现金的期初余额1,237,819,140.8-1,373,533,190.29-
  现金及现金等价物的净增加额-256,282,292.62--135,714,049.49-
公告日期2025-08-292025-04-292025-03-152024-10-31
审计意见(境内)标准无保留意见
TOP↑